Crinetics Pharmaceuticals, Inc. (CRNX) Social Stream
Crinetics Pharmaceuticals Inc (CRNX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRNX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 15 months, CRNX's average price target has gone up $10.23.
CRNX reports an average of 83.22% for its upside potential over the past 51 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CRNX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, CRNX's average broker recommendation rating improved by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRNX as an investment opportunity.
- Crinetics Pharmaceuticals Inc's variance in analysts' estimates is lower than -386.73% of all US stocks.
- Crinetics Pharmaceuticals Inc's average analyst price target is greater than 653.17% of stocks in the small market cap category.
- Crinetics Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 220.67% of Pharmaceutical Products stocks.
- CRNX has a higher number of analysts covering the stock than 513.76% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Crinetics Pharmaceuticals Inc are CRMD, CRBP, and CPRX.
Make investment decisions regarding CRNX using the data that counts. Try POWR Ratings for free.